Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleResearch and Reports

Molecular Action of ADAMTS-13 and Transfusion Therapies of Thrombotic Thrombocytopenic Purpura

Billie Ketelsen
American Society for Clinical Laboratory Science July 2020, 33 (3) 32-36; DOI: https://doi.org/10.29074/ascls.2020002287
Billie Ketelsen
Oakland University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Domain structure of ADAMTS-13. ADAMTS-13 is composed of a metalloproteinase (proteolytic domain), TSP-1–like domains for a total of 8 domains, a cysteine-rich/spacer motif, and 2 CUB structures (peptide-containing domains). The N-terminal domain of ADAMTS-13 is composed of the metalloproteinase, disintegrin, TSP-1, and the cysteine-rich/spacer domains. The C-terminal domains include TSP-2–TSP-8 and the 2 CUB structures.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Cryptic epitopes in the spacer domain that are targeted by autoantibodies to ADAMTS-13.

Tables

  • Figures
    • View popup
    Table 1.

    40-year-old female undergoing treatment TPE for TTP

    Reference RangeOriginal Laboratory Results (Day 1)Day 2Day 3
    Hematology
     Platelet bil/L150–400322237
    Chemistry
     LDH U/L100–240362240190
    Blood bank
     Plasma volume exchange0 mL3000 mL3000 mL
    Day 4Day 5Day 6Day 7 (After TPE)
    Hematology
     Platelet bil/L91112175195
    Chemistry
     LDH U/L176159147152
    Blood bank
     Plasma volume exchange3000 mL3500 mL3500 mL3500 mL

    Treatment was a 6-day course of plasma exchange at 10–15 mL/kg body weight. During treatment, platelet values and LDH values were closely monitored. Platelet values steadily increased throughout treatment, whereas LDH values decreased to within normal range.

    PreviousNext
    Back to top

    In this issue

    American Society for Clinical Laboratory Science: 33 (3)
    American Society for Clinical Laboratory Science
    Vol. 33, Issue 3
    1 Jul 2020
    • Table of Contents
    • Index by author
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Molecular Action of ADAMTS-13 and Transfusion Therapies of Thrombotic Thrombocytopenic Purpura
    (Your Name) has sent you a message from American Society for Clinical Laboratory Science
    (Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Molecular Action of ADAMTS-13 and Transfusion Therapies of Thrombotic Thrombocytopenic Purpura
    Billie Ketelsen
    American Society for Clinical Laboratory Science Jul 2020, 33 (3) 32-36; DOI: 10.29074/ascls.2020002287

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Request Permissions
    Share
    Molecular Action of ADAMTS-13 and Transfusion Therapies of Thrombotic Thrombocytopenic Purpura
    Billie Ketelsen
    American Society for Clinical Laboratory Science Jul 2020, 33 (3) 32-36; DOI: 10.29074/ascls.2020002287
    Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • LEARNING OBJECTIVES
      • ABSTRACT
      • INTRODUCTION
      • GENETIC MUTATIONS AND CONGENITAL TTP
      • INHIBITORS AND ACQUIRED TTP
      • TRANSFUSION THERAPY FOR ACQUIRED TTP
      • CONCLUSION
      • References
    • Figures & Data
    • Info & Metrics
    • PDF

    Related Articles

    • No related articles found.
    • Google Scholar

    Cited By...

    • No citing articles found.
    • Google Scholar

    More in this TOC Section

    • Barriers to Implementation of Quality Management Systems in Laboratories: Lessons from the Southern Africa TB Health Systems Project
    • Polyagglutination: Lectin Isolation for T-Activated Red Cells
    • Strength of Direct Antiglobulin Test as an Indicator of Disease Severity in Autoimmune Hemolytic Anemia
    Show more Research and Reports

    Similar Articles

    Keywords

    • ADAMTS-13 - a disintegrin and metalloproteinase with a thrombospondin type 1 motif - member 13
    • CPP - cryoprecipitate-poor plasma
    • CUB - complement C1r/C1s, Uegf, Bmp1
    • FFP - fresh frozen plasma
    • FP24 - plasma frozen within 24 hours after phlebotomy
    • IgG - immunoglobulin G
    • IgM - immunoglobulin M
    • LDH - lactate dehydrogenase
    • TP - thawed plasma
    • TPE - therapeutic plasma exchange
    • TSP - thrombospondin
    • TTP - thrombotic thrombocytopenic purpura
    • ULVWF - ultra-large von Willebrand factor
    • VWF - von Willebrand factor
    • ADAMTS-13
    • autoantibodies
    • IgG
    • thrombotic thrombocytopenic purpura
    • therapeutic plasma exchange

    © 2025 The American Society for Clinical Laboratory Science

    Powered by HighWire